? CORE B: METABOLOMICS The development of cancer is inherently linked to alterations in cellular metabolism. Exploration of these changes and the underlying regulatory mechanisms, with the goal of enabling new approaches for the diagnosis and treatment of melanoma, is a long-range objective of this P01 Program Project. The primary overall objective for Core B is to apply metabolic profiling methodology developed by core members for the comprehensive assessment of changes in metabolism upon altered ER homeostasis and mitochondrial function in melanoma, all processes that are tightly linked to central metabolism. Core B will fulfill this objective by a unique combination of methodology to comprehensively analyze metabolism, expertise in interpreting analytical results to explain the broader metabolic picture, and requisite experience in enzymology for detailed follow-up studies on metabolic enzymes. Central metabolism was already a focus for study in melanoma by the investigators of this grant in collaboration with the Core B leaders in the first phase of this P01 program.
The Specific Aims of this core are as follows: (1) to provide comprehensive metabolic analytical support to all three collaborating research projects; (2) to characterize the central metabolism of the set of cell lines used in all research projects and Core C (melanoma screening and stratification core); and (3) to provide support to the research projects by assisting in the characterization of enzymes and enzymatic activities. The central method to be used is gas chromatography-mass spectrometry (GC-MS) analysis of polar and apolar metabolites in fractions of cells or medium derived from cultures labeled with stable isotopes (13C). This GC-MS technique yields data on metabolite quantities and also using isotope tracing, on metabolite origins and flux through metabolic pathways. Complemented with other methods to measure substrate uptake (YSI) and for oxygen consumption (Seahorse), it provides a comprehensive assessment of central metabolism. In general, further advances to this novel approach to metabolic analysis will also provide a model for future studies on cancer metabolism and cellular metabolism in general.

Public Health Relevance

? CORE B: METABOLOMICS A fundamental aspect of cancer is altered metabolism. The mission of Core B in this P01 project is to facilitate the study of metabolism in melanoma using a suite of methods to identify and explore changes in metabolic pathways that are essential for cancer cell proliferation and metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA128814-09
Application #
9691265
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Sanford Burnham Prebys Medical Discovery Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
García-Jiménez, Custodia; Goding, Colin R (2018) Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming. Cell Metab :
Theodosakis, Nicholas; Langdon, Casey G; Micevic, Goran et al. (2018) Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer. Pigment Cell Melanoma Res :
Senft, Daniela; Qi, Jianfei; Ronai, Ze'ev A (2018) Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat Rev Cancer 18:69-88
Liu, Xiaoni; Zhang, Shang-Min; McGeary, Meaghan K et al. (2018) KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations. Mol Cancer Ther :
Pathria, Gaurav; Scott, David A; Feng, Yongmei et al. (2018) Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J 37:
Wang, Jake; Perry, Curtis J; Meeth, Katrina et al. (2017) UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res 30:428-435
Falletta, Paola; Sanchez-Del-Campo, Luis; Chauhan, Jagat et al. (2017) Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev 31:18-33
Theodosakis, Nicholas; Micevic, Goran; Langdon, Casey G et al. (2017) p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis. J Invest Dermatol 137:2187-2196
Damsky, W E; Bosenberg, M (2017) Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene 36:5771-5792
Poothong, Juthakorn; Sopha, Pattarawut; Kaufman, Randal J et al. (2017) IRE1? nucleotide sequence cleavage specificity in the unfolded protein response. FEBS Lett 591:406-414

Showing the most recent 10 out of 50 publications